Conmed (CNMD) Tops Q2 EPS by 1c; Raises Outlook
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $35.11 +3.78%
EPS Growth %: -3.5%
Financial Fact:
Weighted average common shares Diluted: 27.95M
Today's EPS Names:
EPAC, SAR, KRUS, More
EPS Growth %: -3.5%
Financial Fact:
Weighted average common shares Diluted: 27.95M
Today's EPS Names:
EPAC, SAR, KRUS, More
Join SI Premium – FREE
Conmed (NASDAQ: CNMD) reported Q2 EPS of $0.46, $0.01 better than the analyst estimate of $0.45. Revenue for the quarter came in at $212.8 million versus the consensus estimate of $207.12 million.
GUIDANCE:
Conmed sees FY2018 EPS of $2.15-$2.20, versus the consensus of $2.17.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- AbbVie updates 2026 EPS guidance after $291M IPR&D charge
- Exyn Technologies reports Q1 2026 results after Nasdaq IPO
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
